Serum Natriuretic Peptides as Differential Biomarkers Allowing for the Distinction between Physiologic and Pathologic Left Ventricular Hypertrophy.
Saved in:
| Title: | Serum Natriuretic Peptides as Differential Biomarkers Allowing for the Distinction between Physiologic and Pathologic Left Ventricular Hypertrophy. |
|---|---|
| Authors: | Dunn ME; 1 Regeneron Pharmaceuticals, Tarrytown, New York, USA., Manfredi TG; 2 Department of Kinesiology, University of Rhode Island, Kingston, Rhode Island, USA., Agostinucci K; 2 Department of Kinesiology, University of Rhode Island, Kingston, Rhode Island, USA., Engle SK; 3 Lilly Research Laboratories, A Division of Eli Lilly and Company, Indianapolis, Indiana, USA., Powe J; 4 Millennium: the Takeda Oncology Company, Cambridge, Masschusettes, USA., King NM; 5 Critical Path Institute, Predictive Safety Testing Consortium, Tucson, Arizona, USA., Rodriguez LA; 6 GlaxoSmithKline, Research Triangle Park, North Carolina, USA., Gropp KE; 7 Pfizer Inc, Groton, Connecticut, USA., Gallacher M; 4 Millennium: the Takeda Oncology Company, Cambridge, Masschusettes, USA., Vetter FJ; 8 Department of Biomedical Engineering, University of Rhode Island, Kingston, Rhode Island, USA., More V; 9 Department of Biomedical and Pharmaceutical Sciences, University of Rhode Island, Kingston, Rhode Island, USA., Shimpi P; 9 Department of Biomedical and Pharmaceutical Sciences, University of Rhode Island, Kingston, Rhode Island, USA., Serra D; 9 Department of Biomedical and Pharmaceutical Sciences, University of Rhode Island, Kingston, Rhode Island, USA., Colton HM; 6 GlaxoSmithKline, Research Triangle Park, North Carolina, USA. |
| Corporate Authors: | Cardiac Hypertrophy Working Group of the Predictive Safety Testing Consortium |
| Source: | Toxicologic pathology [Toxicol Pathol] 2017 Feb; Vol. 45 (2), pp. 344-352. Date of Electronic Publication: 2016 Jul 11. |
| Publication Type: | Journal Article; Research Support, U.S. Gov't, P.H.S. |
| Journal Info: | Publisher: Sage Publications Country of Publication: United States NLM ID: 7905907 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-1601 (Electronic) Linking ISSN: 01926233 NLM ISO Abbreviation: Toxicol Pathol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 27102652 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Serum Natriuretic Peptides as Differential Biomarkers Allowing for the Distinction between Physiologic and Pathologic Left Ventricular Hypertrophy. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Dunn+ME%22">Dunn ME</searchLink>; 1 Regeneron Pharmaceuticals, Tarrytown, New York, USA.<br /><searchLink fieldCode="AU" term="%22Manfredi+TG%22">Manfredi TG</searchLink>; 2 Department of Kinesiology, University of Rhode Island, Kingston, Rhode Island, USA.<br /><searchLink fieldCode="AU" term="%22Agostinucci+K%22">Agostinucci K</searchLink>; 2 Department of Kinesiology, University of Rhode Island, Kingston, Rhode Island, USA.<br /><searchLink fieldCode="AU" term="%22Engle+SK%22">Engle SK</searchLink>; 3 Lilly Research Laboratories, A Division of Eli Lilly and Company, Indianapolis, Indiana, USA.<br /><searchLink fieldCode="AU" term="%22Powe+J%22">Powe J</searchLink>; 4 Millennium: the Takeda Oncology Company, Cambridge, Masschusettes, USA.<br /><searchLink fieldCode="AU" term="%22King+NM%22">King NM</searchLink>; 5 Critical Path Institute, Predictive Safety Testing Consortium, Tucson, Arizona, USA.<br /><searchLink fieldCode="AU" term="%22Rodriguez+LA%22">Rodriguez LA</searchLink>; 6 GlaxoSmithKline, Research Triangle Park, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Gropp+KE%22">Gropp KE</searchLink>; 7 Pfizer Inc, Groton, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Gallacher+M%22">Gallacher M</searchLink>; 4 Millennium: the Takeda Oncology Company, Cambridge, Masschusettes, USA.<br /><searchLink fieldCode="AU" term="%22Vetter+FJ%22">Vetter FJ</searchLink>; 8 Department of Biomedical Engineering, University of Rhode Island, Kingston, Rhode Island, USA.<br /><searchLink fieldCode="AU" term="%22More+V%22">More V</searchLink>; 9 Department of Biomedical and Pharmaceutical Sciences, University of Rhode Island, Kingston, Rhode Island, USA.<br /><searchLink fieldCode="AU" term="%22Shimpi+P%22">Shimpi P</searchLink>; 9 Department of Biomedical and Pharmaceutical Sciences, University of Rhode Island, Kingston, Rhode Island, USA.<br /><searchLink fieldCode="AU" term="%22Serra+D%22">Serra D</searchLink>; 9 Department of Biomedical and Pharmaceutical Sciences, University of Rhode Island, Kingston, Rhode Island, USA.<br /><searchLink fieldCode="AU" term="%22Colton+HM%22">Colton HM</searchLink>; 6 GlaxoSmithKline, Research Triangle Park, North Carolina, USA. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22Cardiac+Hypertrophy+Working+Group+of+the+Predictive+Safety+Testing+Consortium%22">Cardiac Hypertrophy Working Group of the Predictive Safety Testing Consortium</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227905907%22">Toxicologic pathology</searchLink> [Toxicol Pathol] 2017 Feb; Vol. 45 (2), pp. 344-352. <i>Date of Electronic Publication: </i>2016 Jul 11. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, U.S. Gov't, P.H.S. – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Sage+Publications%22">Sage Publications </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7905907 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1533-1601 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201926233%22">01926233 </searchLink><i>NLM ISO Abbreviation: </i>Toxicol Pathol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=27102652 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1177/0192623316634231 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 344 Titles: – TitleFull: Serum Natriuretic Peptides as Differential Biomarkers Allowing for the Distinction between Physiologic and Pathologic Left Ventricular Hypertrophy. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Dunn ME – PersonEntity: Name: NameFull: Manfredi TG – PersonEntity: Name: NameFull: Agostinucci K – PersonEntity: Name: NameFull: Engle SK – PersonEntity: Name: NameFull: Powe J – PersonEntity: Name: NameFull: King NM – PersonEntity: Name: NameFull: Rodriguez LA – PersonEntity: Name: NameFull: Gropp KE – PersonEntity: Name: NameFull: Gallacher M – PersonEntity: Name: NameFull: Vetter FJ – PersonEntity: Name: NameFull: More V – PersonEntity: Name: NameFull: Shimpi P – PersonEntity: Name: NameFull: Serra D – PersonEntity: Name: NameFull: Colton HM IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2017 Feb Type: published Y: 2017 Identifiers: – Type: issn-electronic Value: 1533-1601 Numbering: – Type: volume Value: 45 – Type: issue Value: 2 Titles: – TitleFull: Toxicologic pathology Type: main |
| ResultId | 1 |